Dolca Thomas Selected Research

Dolca Thomas Research Topics

4	Neoplasms (Cancer) 01/2015 - 01/2004
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2012 - 12/2010
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022
1	Rheumatoid Arthritis 01/2016
1	Necrosis 01/2016
1	Mycoses (Diseases, Fungus) 10/2012
1	Lymphoma (Lymphomas) 01/2012
1	Infections 12/2010
1	Epstein-Barr Virus Infections 02/2008
1	Neoplasm Metastasis (Metastasis) 01/2004
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2004
1	Inflammation (Inflammations) 08/2002

3	Biosimilar PharmaceuticalsIBA 01/2016 - 01/2015
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2010 - 01/2004
1	AutoantibodiesIBA 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2016
1	Methotrexate (Mexate)FDA LinkGeneric 01/2016
1	Monoclonal AntibodiesIBA 01/2015
1	Abatacept (Orencia)FDA Link 10/2012
1	Immunomodulating AgentsIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	AntigensIBA 02/2008
1	Sirolimus (Rapamycin)FDA Link 01/2004
1	Transcription Factors (Transcription Factor)IBA 08/2002
1	NF-kappa B (NF-kB)IBA 08/2002

2	Therapeutics 01/2022 - 01/2016
1	Biological Therapy 01/2015